当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:206.44亿  总市值:207.57亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金603,829,040.383,507,911,150.92,312,310,695.981,509,250,509.84
收到的税费返还423,278.572,907,422.082,755,600.382,754,217.07
收到其他与经营活动有关的现金48,234,574.46352,789,344.21226,792,137.3155,532,111.59
经营活动现金流入的平衡项目0000
经营活动现金流入小计652,486,893.413,863,607,917.192,541,858,433.661,667,536,838.5
购买商品、接受劳务支付的现金492,198,590.081,576,082,330.171,057,292,663.53649,285,838.08
支付给职工以及为职工支付的现金315,971,121.411,153,821,278.81925,531,974.13634,754,891.07
支付的各项税费38,498,076.35206,939,887.39135,466,714.45104,836,253.06
支付其他与经营活动有关的现金202,912,883.28831,041,595.31566,379,433.63359,136,677.41
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,049,580,671.123,767,885,091.682,684,670,785.741,748,013,659.62
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-397,093,777.7195,722,825.51-142,812,352.08-80,476,821.12
二、投资活动产生的现金流量:
收回投资收到的现金1,822,875,351.4511,960,221,087.357,580,390,516.793,565,558,577.15
取得投资收益收到的现金20,132,426.6697,832,649.4476,456,772.439,576,941.72
处置固定资产、无形资产和其他长期资产收回的现金净额112,034.57562,147.674,289,214.394,229,537.23
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,843,119,812.6812,058,615,884.467,661,136,503.583,609,365,056.1
购建固定资产、无形资产和其他长期资产支付的现金170,600,959.19529,480,642.08364,136,982.78196,062,319.31
投资支付的现金1,894,099,219.4611,843,551,048.017,824,082,496.953,357,396,010.44
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,064,700,178.6512,373,031,690.098,188,219,479.733,553,458,329.75
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-221,580,365.97-314,415,805.63-527,082,976.1555,906,726.35
三、筹资活动产生的现金流量:
取得借款收到的现金570,960,000192,796,406.9161,376,240.15113,088,937.05
收到其他与筹资活动有关的现金-53,078,767.553,078,767.553,078,767.5
筹资活动现金流入平衡项目0000
筹资活动现金流入小计570,960,000245,875,174.4214,455,007.65166,167,704.55
偿还债务支付的现金7,585,692.7337,730,696.5422,792,473.4613,500,000
分配股利、利润或偿付利息支付的现金2,881,529.1453,544,931.4450,834,608.286,883,432.31
其中:子公司支付给少数股东的股利、利润-3,181,5003,181,5003,181,500
支付其他与筹资活动有关的现金11,222,169.46837,751,898.37457,640,013.93443,493,138.59
筹资活动现金流出平衡项目0000
筹资活动现金流出小计21,689,391.33929,027,526.35531,267,095.67463,876,570.9
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额549,270,608.67-683,152,351.95-316,812,088.02-297,708,866.35
四、汇率变动对现金及现金等价物的影响1,140,128.545,121,479.4919,769,275.4521,750,618.43
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-68,263,406.51-856,723,852.58-966,938,140.8-300,528,342.69
加:期初现金及现金等价物余额2,698,417,224.43,555,141,076.983,555,141,076.983,555,141,076.98
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,630,153,817.892,698,417,224.42,588,202,936.183,254,612,734.29
补充资料:
净利润--912,101,083.16-20,153,227.36
资产减值准备-438,444,688.41-60,685,522.23
固定资产和投资性房地产折旧-362,164,765.23-181,009,572.35
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-362,164,765.23-181,009,572.35
无形资产摊销-67,701,502.82-32,483,252.66
长期待摊费用摊销-63,033,131.31-24,800,327.22
处置固定资产、无形资产和其他长期资产的损失-631,684.81--2,685,435.04
固定资产报废损失-5,686,770.66-3,764,822.08
公允价值变动损失-33,175,650.35-7,105,994.48
财务费用--10,116,817.26-15,403,515.82
投资损失-43,626,260.23-11,089,127.82
递延所得税-22,868,842.15--21,701,774.89
其中:递延所得税资产减少-11,109,403.54--21,152,344.92
递延所得税负债增加-11,759,438.61--549,429.97
存货的减少--34,200,452.89-849,789.6
经营性应收项目的减少--438,842,458.36--477,583,050.76
经营性应付项目的增加-284,489,065.92-33,953,885.33
其他-115,499,013.36--
不涉及现金收支的投资和筹资活动金额其他项目-15,402,331.25-9,833,858.05
现金的期末余额-2,698,417,224.4-3,254,612,734.29
减:现金的期初余额-3,555,141,076.98-3,555,141,076.98
公告日期2025-04-262025-04-262024-10-262024-08-24
审计意见(境内)标准无保留意见
TOP↑